| PERIOD ENDING | 31-May-08 | 29-Feb-08 | 30-Nov-07 | 31-Aug-07 | | Total Revenue | 764,150 | 723,950 | 860,119 | 716,227 | | Cost of Revenue | 466,200 | 438,200 | 488,800 | 431,898 | | | Gross Profit | 297,950 | 285,750 | 371,319 | 284,329 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 221,975 | 204,725 | 225,213 | 192,596 | | Non Recurring | (4,536) | 3,636 | 14,052 | 2,845 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 80,511 | 77,389 | 132,054 | 88,888 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,100 | 3,300 | 2,318 | 2,411 | | Earnings Before Interest And Taxes | 83,611 | 80,689 | 134,372 | 91,299 | | Interest Expense | 12,743 | 14,757 | 15,710 | 15,805 | | Income Before Tax | 70,868 | 65,932 | 118,662 | 75,494 | | Income Tax Expense | 21,827 | 19,873 | 36,256 | 23,200 | | Minority Interest | (235) | (65) | (27) | (75) | | | | Net Income From Continuing Ops | 53,377 | 51,423 | 87,598 | 56,849 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,377 | 51,423 | 87,598 | 56,849 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $53,377 | $51,423 | $87,598 | $56,849 |
|
1.49% Nasdaq 
0.27%
Income Statement
